Atlas Trials

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT00607438 · TERMINATED

Trial details

NCT number
NCT00607438
Sponsor
Veeda Oncology
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-09-01
Primary completion
2009-05-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.